VIDO-InterVac running vaccine trial in Africa as Omicron variant spreads

• Leave a comment
• Share this item on Facebook
• Share this item via WhatsApp
• Send this page to someone via email
• Share this item on Twitter
• Share this item on Reddit
• Share this item on Pinterest
• Share this item on Linkedin

VIDO-InterVac director and CEO Dr. Volker Gerdts tells Global News Morning they are trialling their Saskatoon-made COVID-19 vaccine in Africa — and gives his thoughts on the Omicron variant.

Advertisement

Subscribe to updates from Global News

Unsubscribe from Global News updates

Journalistic standards Report an error

• Leave a comment
• Share this item on Facebook
• Share this item via WhatsApp
• Send this page to someone via email
• Share this item on Twitter
• Share this item on Reddit
• Share this item on Pinterest
• Share this item on Linkedin

More Videos

• Flex school program discussed on Family Matters
• Live print studio showcased at Remai Modern
• Metric Design discusses upcoming trends
• Saskatoon Fire Department discusses dry weather and fire
• Former NHL player teams up with addictions recovery center
• The connection between allergies and hormone health

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article